Oncology
Poexho®
Indications for Use:
Reduction of the duration of neutropenia and the incidence of febrile neutropenia in adult patients receiving cytotoxic chemotherapy for malignant neoplasms (excluding chronic myeloid leukemia and myelodysplastic syndromes).
Quality control
at all stages of production
at all stages of production
